Interleukin 1-dependent and -independent mouse melanoma metastases

Journal of the National Cancer Institute

Volumn 89, Issue 9, 1997, Pages 645-651

  Anasagasti, Miren Josu ^a   Olaso, Elvira ^a   Calvo, Fernando ^a   Mendoza, Lorea ^a   Martin, Javier José ^a   Bidaurrazaga, Joseba ^a   Vidal Vanaclocha, Fernando ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ADOLESCENT; ADRENAL GLAND; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW METASTASIS; CENTRAL NERVOUS SYSTEM METASTASIS; CONTROLLED STUDY; DIGESTIVE SYSTEM; HEART METASTASIS; KIDNEY METASTASIS; LIVER METASTASIS; LUNG METASTASIS; MALE; MELANOMA; METASTASIS; MOUSE; NONHUMAN; PANCREAS; SKELETAL MUSCLE; SKIN; SKIN METASTASIS; TESTIS;

EID: 0030955993     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/89.9.645     Document Type: Article

References (39)

1. Bertomeu M, Gallo S, Lauri D, Haas TA, Orr FW, Bastida E, et al. Interleukin 1-induced cancer cell/endothelial cell adhesion in vitro and its relationship to metastasis in vivo: role of vessel wall 13-HODE synthesis and integrin expression. Clin Exp Metastasis 1993;11:243-50.
2. Giavazzi R, Garofalo A, Bani MR, Abbate M, Ghezzi P, Boraschi D, et al. Interleukin 1-induced augmentation of experimental metastases from a human melanoma in nude mice. Cancer Res 1990;50:4771-5.
3. Rice GE, Bevilacqua MP. An inducible endothelial cell surface glycoprotein mediates melanoma adhesion. Science 1989;246:1303-6.
4. Chirivi RG, Garofalo A, Padura IM, Mantovani A, Giavazzi R. Interleukin 1 receptor antagonist inhibits the augmentation of metastasis induced by interleukin 1 or lipopolysaccharide in a human melanoma/nude mouse system. Cancer Res 1993;53:5051-4.
5. Vidal-Vanaclocha F, Amezaga C, Asumendi A, Kaplanski G, Dinarello CA. Interleukin-1 receptor blockade reduces the number and size of murine B16 melanoma hepatic metastases. Cancer Res 1994;54:2667-72.
6. Okahara H, Yagita H, Miyake K, Okumura K. Involvement of very late antigen 4 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) in tumor necrosis factor alpha enhancement of experimental metastasis. Cancer Res 1994;54:3233-6.
7. Garofalo A, Chirivi RG, Foglieni C, Pigott R, Mortarini R, Martin-Padura I, et al. Involvement of the very late antigen 4 integrin on melanoma in interleukin 1-augmented experimental metastases. Cancer Res 1995;55: 414-9.
8. Vidal-Vanaclocha F, Alvarez A, Asumendi A, Urcelay B, Tonino P, Dinarello CA. Interleukin 1 (IL-1)-dependent melanoma hepatic metastasis in vivo; increased endothelial adherence by IL-1-induced mannose receptors and growth factor production in vitro. J Natl Cancer Inst 1996;88:198-205.
9. Bennicelli JL, Elias J, Kern J, Guerry D 4th. Production of interleukin 1 activity by cultured human melanoma cells. Cancer Res 1989;49: 930-5.
10. Burrows FJ, Haskard DO, Hart IR, Marshall JF, Selkirk S, Poole S, et al. Influence of tumor-derived interleukin 1 on melanoma-endothelial cell interactions in vivo. Cancer Res 1991;51:4768-75.
11. Kock A, Schwarz T, Urbanski Z, Pen Z, Vetterlein M, Micksche M, et al. Expression and release of interleukin-1 by different human melanoma cell lines. J Natl Cancer Inst 1989; 81:36-42.
12. 2 production by hepatic sinusoidal endothelium in response to B16 melanoma cell adhesion. J Cell Physiol 1996;167:314-23.
13. Mattei S, Colombo MP, Melani C, Silvani A, Parmiani G, Herlyn M. Expression of cytokine/ growth factors and their receptors in human melanoma and melanocytes. Int J Cancer 1994; 56:853-7.
14. Allen AC, Spitz SA. A clinicopathologic analysis of malignant melanoma. Diagnosis and prognosis. Cancer 1983;6:1-45.
15. Akslen LA, Heuch I, Hartveit F. Metastatic patterns in autopsy cases of cutaneous melanoma. Invasion Metastasis 1988;8:193-204.
16. de la Monte SM, Moore GW, Hutchins GM. Patterned distribution of metastases from malignant melanoma in humans. Cancer Res 1983;43:3427-33.
17. Bani MR, Garofalo A, Scanziani E, Giavazzi R. Effect of interleukin-1-beta on metastasis formation in different tumor systems. J Natl Cancer Inst 1991;83:119-23.
18. Arguello F, Baggs RB, Graves BT, Harwell SE, Cohen HJ, Frantz CN. Effect of IL-1 on experimental bone/bone-marrow metastases. Int J Cancer 1992;52:802-7.
19. (/9) Fidler IJ, Kripke ML. Metastasis results from preexisting variant cells within a malignant tumor. Science 1977;197:893-5.
20. Alterman AL, Fornabaio DM, Stackpole CW. Metastatic dissemination of B16 melanoma: pattern and sequence of metastasis. J Natl Cancer Inst 1985;75:691-702.
21. Barbera-Guillem E, Barcelo JR, Urcelay B, Alonso-Varona AI, Vidal-Vanaclocha F. Noncorrelation between implantation and growth of tumor cells for their final metastatic efficiency. Invasion Metastasis 1988;8:266-84.
22. Stackpole CW, Alterman AL, Valle EF. B16 melanoma variants selected by one or more cycles of spontaneous metastasis to the same organ fail to exhibit organ specificity. Clin Exp Metastasis 1991;9:319-32.
23. Hart IR, Fidler IJ. Role of organ selectivity in the determination of metastastic patterns of B16 melanoma. Cancer Res 1980;40:2281-7.
24. Weiss L, Ward PM, Harlos JP, Holmes JC. Target organ patterns of tumors in mice following the arterial dissemination of B16 melanoma cells. Int J Cancer 1984;33: 825-30.
25. Glaves D. Metastasis: reticuloendothelial system and organ retention of disseminated malignant cells. Int J Cancer 1980;26:115-22.
26. Dinarello CA. Biological basis for interleukin-1 in disease. Blood 1996;87:2095-147.
27. Anasagasti MJ, Alvarez A, Martin JJ, Mendoza L, Vidal-Vanaclocha F. Sinusoidal endothelium release of hydrogen peroxide enhances VLA-4 mediated melanoma cell adherence and tumor cytotoxicity during interleukin-1 promotion of hepatic melanoma metastasis. Hepatology 1997;25:8406.
28. Vidal-Vanaclocha F, Asumendi A, Rocha M, Barbera-Guillem E. Participation of endothelial cell mannose receptors in the B16 melanoma cell adhesion to the hepatic sinusoidal endothelium. In: Knook D, Wisse E, editors. Cells of the hepatic sinusoid, 4. Leiden: Kupffer Cell Foundation, 1993:555-8.
29. Librach CL, Feigenbaum SL, Bass KE, Cui TY, Verastas N, Sadovsky Y, et al. Interleukin-1 beta regulates human cytotrophoblast metalloproteinase activity and invasion in vitro. J Biol Chem 1994;269:17125-31.
30. Gutman M, Singh RK, Xie K, Bucana CD, Fidler IJ. Regulation of interleukin-8 expression in human melanoma cells by the organ environment. Cancer Res 1995;55:2470-5.
31. Lu C, Kerbel RS. IL-6 functions as an autocrine growth stimulating factor in human melanoma cell lines from advanced stages of tumor progression but as a growth inhibitor in early-stages melanoma cells. Clin Exp Metastasis 1992;10(Suppl 1):63.
32. Zachariae CO, Thestrup-Pedersen K, Matsushima K. Expression and secretion of leukocyte chemotactic cytokines by normal human melanocytes and melanoma cells. J Invest Dermatol 1991;97:593-9.
33. Singh RK, Gutman M, Radinsky R, Bucana C, Fidler IJ. Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice. Cancer Res 1994;54: 3242-7.
34. Fan TP, Hu DE, Guard S, Gresham GA, Watling KJ. Stimulation of angiogenesis by substance P and interleukin-1 in the rat and its inhibition by NK1 or interleukin-1 receptor antagonists. Br J Pharmacol 1993;110:43-9.
35. Hu DE, Hori Y, Presta M, Gresham GA, Fan TP. Inhibition of angiogenesis in rats by IL-1 receptor antagonist and selected cytokine antibodies. Inflammation 1994;18:45-58.
36. Olaso E, Santisteban A, Vidal-Vanaclocha F. Role of tumor-activated hepatic stellate cells during experimental melanoma metastasis development in murine liver. In: Wisse E, Knook DL, Balabaud C, editors. Cells of the hepatic sinusoid, 6. Leiden: Kupffer Cell Foundation. In press.
37. Vidal-Vanaclocha F, Alvarez A, Asumendi A, Anasagasti MJ, Dinarello CA. Juxtacrine activation of liver sinusoidal endothelium by B16 melanoma cell surface-associated IL-1 stimulates on site release of prometastatic factors. In: Knook DL, Wisse E, editors. Cells of the hepatic sinusoid. 5. Leiden: Kupffer Cell Foundation, 1995:119-23.
38. Paget S. The distribution of secondary growths in cancer of the breast. Lancet 1889;1:571-3.
39. Fidler IJ, Grays E, Cifone MA, Barnes Z, Bucana C. Demonstration of multiple phenotypic diversity in a murine melanoma of recent origin. J Natl Cancer Inst 1981;67:947-56.